BMGL — Basel Medical Balance Sheet
0.000.00%
Last trade - 00:00- $28.05m
- $23.04m
- SG$10.05m
Annual balance sheet for Basel Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 1.66 | 1.31 | 2.04 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 13.9 | 13.3 | 12.4 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 15.7 | 14.8 | 16.2 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 1.18 | 0.579 | 0.058 |
| Other Long Term Assets | |||
| Total Assets | 16.8 | 15.4 | 16.3 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 7.19 | 6.47 | 7.16 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 13.1 | 9.89 | 8.75 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 3.71 | 5.49 | 7.56 |
| Total Liabilities & Shareholders' Equity | 16.8 | 15.4 | 16.3 |
| Total Common Shares Outstanding |